Life Sciences et droit de la santé
Wenger Plattner dispose depuis plusieurs années d'une vaste expérience, constamment mise à jour et étoffée, dans les domaines des Life Sciences et du droit de la santé.
Ces domaines présentent une complexité certaine dans la mesure où ils soulèvent des questions relevant aussi bien du droit public général, du droit privé ainsi que d'autres lois spéciales.
Nos clients sont des hôpitaux, des entreprises pharmaceutiques ou de biotechnologie, des assurances, des organisations ou institutions actives dans l'économie de la santé, ainsi que des personnes privées.
Contact
Autres spécialistes
Publications
Braun Martina / Mayoraz Jean-François
Beurteilung der Wirtschaftlichkeit von Arzneimitteln im Rahmen der dreijährlichen Überprüfung
Urteil Bundesverwaltungsgerichts BVGer C-6093/2018 vom 17. März 2020, LSR 2020, S. 163
Braun Martina / Conti Carlo / Künzler Oliver
GLI - Pricing & Reimbursement 2020
Every resident in Switzerland is mandatorily obliged to be covered by basic healthcare
insurance which provides for a wide range of services. Persons with lower incomes are, in
principle, granted reductions on the premiums payable for such basic healthcare insurance.
Thus, every resident in Switzerland is granted access to affordable healthcare.
In general, therapeutic products are only reimbursed if they are listed on the so-called
specialty list. In order to be listed thereon, a medicinal product must be admitted by the
competent Swiss authority, and must satisfy the criteria of effectiveness, functionality and
economic efficiency, based on which the maximum price for the therapeutic product in
question is determined.
Conti Carlo / Künzler Oliver / Mayoraz Jean-François / Müller Melanie
The Pharma Legal Handbook Switzerland
Regulatory, Pricing and Reimbursement Overview · Preclinical and Clinical Trial Requirements · Marketing, Manufacturing, Packaging and Labeling Advertising · Traditional Medicines and OTC Products · Product Liability · Patents and Trademarks · Regulatory Reforms | Pharma Board Room, London 2020
Braun Martina / Conti Carlo / Künzler Oliver
GLI - Pricing & Reimbursement 2019
Every resident in Switzerland is mandatorily obliged to be covered by basic healthcare insurance which provides for a wide range of services. Persons with lower incomes are, in principle, granted reductions on the premiums payable for such basic healthcare insurance. Thus, every resident in Switzerland is granted access to affordable healthcare.
In general, therapeutic products are only reimbursed if they are listed on the so-called specialty list. In order to be listed thereon, a medicinal product must be admitted by the competent Swiss authority, and has to satisfy the criteria of effectiveness, functionality and economic efficiency, based on which the maximum price for the therapeutic product in question is determined.